• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Trimedx picks up Aramark’s healthcare technologies business

Trimedx picks up Aramark’s healthcare technologies business

September 17, 2018 By Nancy Crotti

Aramark (NYSE: ARMK) is quitting the healthcare technologies business, announcing today that it has agreed to sell that part of its business for $300 million to clinical engineering and asset management company Trimedx.

Best known for its food service, uniform and facilities businesses, Aramark bought the Charlotte, N.C.-based healthcare business in 2001. It has been in operation for over 45 years and employs more than 1,500 technicians, engineers and program staff. Trimedx provides management programs for for maintenance and refurbishment of clinical equipment at more than 500 hospitals and healthcare facilities.

“This transaction represents the latest step in our commitment to deliver sustainable shareholder value, while also increasing our financial flexibility,” said Aramark president & CEO Eric Foss in a prepared statement. “We will use the majority of proceeds to strengthen our balance sheet through debt reduction and will also repurchase $50 million of shares after closing of the sale.”

Trimedx (Indianapolis) started as a hospital biomedical engineering department in the 1990s and now helps more than1,800 providers achieve sustainable savings and efficiencies, according to that company’s website.

“We are excited to bring our technology and service model to a greater number of healthcare providers, delivering a comprehensive and differentiated clinical asset management program in an ever-changing environment,” said Trimedx CEO Henry Hummel in another prepared statement.  “We look forward to Aramark HCT’s talented associates joining the Trimedx team to support our strategic operating model focused on partnering with healthcare providers to drive measurable and persistent value.”

The divestiture of its healthcare technologies business will allow Aramark to “further focus our portfolio around our core food, facilities and uniforms businesses,” Foss added.

The transaction is subject to customary closing conditions and regulatory approvals, and is expected to close in the fourth quarter of calendar 2018. Aramark’s stock was up to $42.48 on the news this morning.

 

Filed Under: Business/Financial News, Wall Street Beat Tagged With: aramark, trimedx

More recent news

  • CVRx taps new CFO from Nyxoah
  • BD brings on new chief information and digital officer from Lenovo
  • Cooper Companies continues to see activist pressure to sell divisions, replace CEO
  • Cordis earns FDA nod for Selution SLR drug-eluting balloon
  • Siemens Healthineers links with Novo to advance liver fibrosis blood test

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy